Compare Agilent Technologies Inc (A) vs Innodata Inc (INOD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Innodata Inc — how do they compare? Agilent Technologies Inc trades at $129.02 (market cap $37.04B), while Innodata Inc trades at $68.58 (market cap $2.28B). The key difference: Agilent Technologies Inc is far larger — about 16.2× Innodata Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| A | INOD | |
|---|---|---|
Market Cap | $37.04B | $2.28B |
Sector | Health | Technology |
52-Week High | $157.20 | $121.50 |
52-Week Low | $110.24 | $34.45 |
Enterprise Value | $38.59B | $2.16B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Innodata (INOD) trades at $73.12, up 6.16% today but down 33% over the past month after a strong AI-driven rally earlier this year. The stock shows bearish technical signals with support at $69 and resistance at $76. Fundamentally, the company reported strong Q1 2026 earnings with EPS of $0.42 beating expectations of $0.13, driven by 47% margins and AI data services growth. Revenue reached $90.1M in Q1 2026 (Zacks Investment Research, 2026-06-03).
Outlook remains positive with 60% analyst buy ratings and a $130 consensus price target, but risks include high valuation (P/E 65.29), insider selling, and dependence on AI sector momentum. The recent CFO appointment (Accesswire, 2026-06-17) supports growth execution, yet volatility near multi-month highs requires caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →
